Dysregulation of the miR-325–3p/DPAGT1 axis supports HBV-positive HCC chemoresistance
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 519 (2) , 358-365
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Anhui Province
This publication has 34 references indexed in Scilit:
- Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancerOral Oncology, 2012
- Pharmacogenetics of genes across the doxorubicin pathwayExpert Opinion on Drug Metabolism & Toxicology, 2011
- Overexpression of DPAGT1 Leads to Aberrant N-Glycosylation of E-Cadherin and Cellular Discohesion in Oral CancerCancer Research, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Inverse Correlation between the Extent of N-Glycan Branching and Intercellular Adhesion in EpitheliaJournal of Biological Chemistry, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- A hypomorphic allele of the first N-glycosylation gene, ALG7, causes mitochondrial defects in yeastBiochimica et Biophysica Acta (BBA) - General Subjects, 2005
- MicroRNAsCell, 2004
- Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) Causes a Novel Congenital Disorder of Glycosylation Type IjHuman Mutation, 2003